Radiation Oncology/Unsealed sources

< Radiation Oncology

See also: Isotopes used in Radiation Oncology

For bone metastases

These have usefulness in treating blastic bone lesions (basically anything that lights up a bone scan). The dose limiting toxicity is bone marrow. Observe platelet counts.


Gets taken up in bone
Not commonly used
Calcium analog, gets taken up in bone
Long half life (50.5 days physical half-life)
Usual dose 4 mCi (supplied as a 4 mCi vial)
May also be dosed at 0.040-0.060 mCi/kg
Bound to a tetraphosphonate, which gets taken up in area of active
Usual dose 1 mCi/kg (may use 0.5 mCi/kg)
Short half life (about 3 days)
Can repeat dose after about 6-8 weeks
Lowest effective range (compared to Sr and P) and thus lower bone marrow toxicity
Can be used for imaging also due to its photon component


P-32



Research

At the ITU (Institute for Transuranium Research; website) work is being done on Alpha-Immunotherapy, an experimental method using antibodies bound to alpha isotopes. Bismuth-213 is one of the isotopes which has been used. This is made by the alpha decay of Ac-225. The generation of one shortlived isotope from longer lived isotope is a useful method of providing a portable supply of a shortlived isotope. This is similar to the generation of technetium-99m by a technetium cow. The actinium-225 is made by the irradation of radium-226 with a cyclotron.

Guidelines

Reviews

Samarium-153:

This article is issued from Wikibooks. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.